Stock Rises For Weeks Amid This Cancer Research Company's Success

The Unstoppable Rise of IBRX: A Deep Dive into Its Two-Week Surge.

The financial world has been abuzz with the recent bullish run of ImmunityBio, Inc. (NASDAQ: IBRX). The biotechnology company, known for its innovative solutions in tackling cancer and infectious diseases, has seen a remarkable surge in its stock value over the past two weeks. On November 3rd alone, the stock peaked at a high of $3.84.

This continuous gr…